Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Chang Fang

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of the Chinese Medical Association : JCMA|June 25, 2016
Efficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: A multicenter retrospective pilot studyI-Chih Chen, Cheng-Han Lee, Ching-Chang Fang, et al.
Journal of Atherosclerosis and Thrombosis|January 24, 2014
Gender disparities in optimal lipid control among patients with coronary artery diseaseChun-Yen Chen, Shao-Yuan Chuang, Ching-Chang Fang, et al.
Plos One|May 12, 2021
Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapyMing-Yun Ho, Po-Wei Chen, Wen-Han Feng, et al.
Journal of Clinical Medicine|June 5, 2020
P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionPo-Wei Chen, Wen-Han Feng, Ming-Yun Ho, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor MonotherapySheng-Wei Huang, Po-Wei Chen, Wen-Han Feng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 27, 2013
Guideline-adherent therapy in patients with cardiovascular diseases in TaiwanJiann-Shing Jeng, Wei-Hsian Yin, Chin-Chou Huang, et al.
Plos One|March 11, 2015
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in TaiwanLi-Ting Ho, Wei-Hsian Yin, Shao-Yuan Chuang, et al.
Acta Cardiologica Sinica|May 31, 2018
2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in TaiwanYi-Heng Li, Chih-Yuan Fang, I-Chang Hsieh, et al.
Journal of Clinical Medicine|March 29, 2023
Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in TaiwanPatrick Yan-Tyng Liu, Fang-Ju Lin, Chih-Fan Yeh, et al.
Biomedical Journal|August 14, 2023
A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation studyYu-Chung Hsiao, Thung-Lip Lee, Fang-Ju Lin, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of the Chinese Medical Association : JCMA|June 25, 2016
Efficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: A multicenter retrospective pilot studyI-Chih Chen, Cheng-Han Lee, Ching-Chang Fang, et al.
Journal of Atherosclerosis and Thrombosis|January 24, 2014
Gender disparities in optimal lipid control among patients with coronary artery diseaseChun-Yen Chen, Shao-Yuan Chuang, Ching-Chang Fang, et al.
Plos One|May 12, 2021
Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapyMing-Yun Ho, Po-Wei Chen, Wen-Han Feng, et al.
Journal of Clinical Medicine|June 5, 2020
P2Y12 Inhibitor Monotherapy with Clopidogrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionPo-Wei Chen, Wen-Han Feng, Ming-Yun Ho, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor MonotherapySheng-Wei Huang, Po-Wei Chen, Wen-Han Feng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 27, 2013
Guideline-adherent therapy in patients with cardiovascular diseases in TaiwanJiann-Shing Jeng, Wei-Hsian Yin, Chin-Chou Huang, et al.
Plos One|March 11, 2015
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in TaiwanLi-Ting Ho, Wei-Hsian Yin, Shao-Yuan Chuang, et al.
Acta Cardiologica Sinica|May 31, 2018
2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in TaiwanYi-Heng Li, Chih-Yuan Fang, I-Chang Hsieh, et al.
Journal of Clinical Medicine|March 29, 2023
Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in TaiwanPatrick Yan-Tyng Liu, Fang-Ju Lin, Chih-Fan Yeh, et al.
Biomedical Journal|August 14, 2023
A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation studyYu-Chung Hsiao, Thung-Lip Lee, Fang-Ju Lin, et al.
Pageof 4